Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDAK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3%   Bankruptcy risk   1.5% 1.8% 1.5% 1.8% 2.7% 1.4% 13.7% 11.0%   Credit score (0-100)   78 73 78 72 59 77 15 22   Credit rating   A A A A BBB A BB BB   Credit limit (kDKK)   10.5 1.4 13.9 3.0 0.0 19.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,397 1,124 1,188 2,616 2,656 1,868 0.0 0.0   EBITDA   863 567 626 2,032 2,022 898 0.0 0.0   EBIT   863 567 626 2,032 2,022 898 0.0 0.0   Pre-tax profit (PTP)   858.5 529.7 665.1 1,987.2 1,981.3 820.2 0.0 0.0   Net earnings   668.6 412.4 518.2 1,549.0 1,545.0 638.7 0.0 0.0   Pre-tax profit without non-rec. items   859 530 665 1,987 1,981 820 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,516 1,823 2,234 2,583 2,428 1,466 786 786   Interest-bearing liabilities   0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0   Balance sheet total (assets)   2,465 2,450 2,750 4,484 3,045 2,893 786 786   Net Debt   -1,453 -1,965 -1,842 -1,642 -1,641 -1,107 -786 -786     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,397 1,124 1,188 2,616 2,656 1,868 0.0 0.0   Gross profit growth   76.6% -19.6% 5.7% 120.2% 1.5% -29.7% -100.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,465 2,450 2,750 4,484 3,045 2,893 786 786   Balance sheet change%   48.8% -0.6% 12.3% 63.0% -32.1% -5.0% -72.8% 0.0%   Added value   863.0 566.5 625.9 2,032.3 2,021.9 898.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   61.8% 50.4% 52.7% 77.7% 76.1% 48.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.6% 23.8% 26.5% 57.0% 54.3% 30.4% 0.0% 0.0%   ROI %   71.8% 35.0% 34.0% 85.6% 81.0% 45.9% 0.0% 0.0%   ROE %   54.7% 24.7% 25.5% 64.3% 61.7% 32.8% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   61.5% 74.4% 83.8% 57.6% 81.9% 52.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -168.3% -346.8% -294.2% -80.8% -81.1% -123.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 1.7% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 310.4% 403.7% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   2.5 3.7 5.8 2.2 5.1 1.6 0.0 0.0   Current Ratio   2.6 3.9 5.3 2.4 4.9 2.0 0.0 0.0   Cash and cash equivalent   1,452.8 1,964.5 1,841.7 1,641.7 1,681.5 1,107.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   887.4 1,244.4 1,591.4 2,574.1 2,419.1 1,457.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 567 626 2,032 2,022 898 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 567 626 2,032 2,022 898 0 0   EBIT / employee   0 567 626 2,032 2,022 898 0 0   Net earnings / employee   0 412 518 1,549 1,545 639 0 0